Latest Molecular Diagnostics Innovation News

Page 1 of 1

Genetic Signatures Accelerates Growth Amid Strategic Overhaul and $20M Loss

Genetic Signatures Limited reported a 63% revenue surge to $15.9 million in FY25, driven by strong Australian sales and progress in EMEA, while navigating a $20.1 million net loss and a strategic pivot towards partnerships for automated diagnostics.

Ada Torres

25 Aug 2025

Browse the archive

Full archive

Aug 2026 July 2026 June 2026 May 2026 Apr 2026 Mar 2026 Feb 2026 Jan 2026